Autolus Therapeutics Plc (AUTL)

1.565 -0.24 (-13.54%) USD  |  NASDAQ  |  Jan 12, 12:32
More

Autolus Therapeutics Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc --
Mereo BioPharma Group Plc --
Bicycle Therapeutics Plc Upgrade
Adaptimmune Therapeutics Plc Upgrade